Design of clinical intelligent percutaneous myocardial laser revascularization operating platform software
暂无分享,去创建一个
[1] F. Zhang,et al. Self-reported insomnia and coronary heart disease in the elderly , 2016, Clinical and experimental hypertension.
[2] K. Davidson,et al. Meta-analysis of perceived stress and its association with incident coronary heart disease. , 2012, The American journal of cardiology.
[3] Q. She,et al. One-year clinical outcome of a randomized trial of polymer-free paclitaxel-eluting stents versus biodegradable polymer-based rapamycin-eluting stents in patients with coronary heart disease. , 2012, Journal of interventional cardiology.
[4] A. Milano,et al. Transmyocardial laser revascularization 12 years later. , 2010, Interactive cardiovascular and thoracic surgery.
[5] C. Dintsios,et al. Drug-eluting stents vs. coronary artery bypass-grafting in coronary heart disease , 2008, GMS health technology assessment.
[6] L. Sharples,et al. Percutaneous myocardial laser revascularization in patients with refractory angina pectoris. , 2003, The American journal of cardiology.
[7] Lang Li,et al. Comparative Efficacy and Safety of Drug-Eluting Stent and Conventional Therapies in Coronary Heart Disease Patients with In-Stent Restenosis: A Meta-Analysis , 2013, Cell Biochemistry and Biophysics.
[8] D. Dudek,et al. [Left ventricular systolic function in patients with refractory angina pectoris treated with percutaneous myocardial laser revascularisation, results of long-term follow-up]. , 2004, Przeglad lekarski.
[9] A. Coats,et al. Cardiac and blood pressure responses to mental stress in reactive hypertensives. , 1991, Clinical and experimental hypertension. Part A, Theory and practice.